TREATMENT OF BREAKTHROUGH AND PREVENTION OF REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PEDIATRIC CANCER PATIENTS: CLINICAL PRACTICE GUIDELINE UPDATE

Pediatric Oncology Group of Ontario, The Hospital for Sick Children, NHS Trust, Stanford Cancer Institute, Rutgers Cancer Institute of New Jersey, McMaster Children’s Hospital, Alberta Children’s Hospital, University of Calgary, University of New Mexico,

The guideline addresses the management of CINV, focusing on both acute and delayed phases. It reviews existing evidence and provides recommendations based on systematic reviews and randomized controlled trials involving pediatric patients. The document aims to improve patient outcomes by offering evidence-based strategies for managing nausea and vomiting associated with chemotherapy in children.